Viewing nowBastia Tablet (Donepezil Hydrochloride)
Donepezil Hydrochloride 5mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

MFDS item code 200708603 · Notified 2007.07.25 · Insurance code 653000830
Treatment of symptoms of Alzheimer-type dementia
This medication is used for the treatment of symptoms of Alzheimer's dementia.
○ Adults: Administer donepezil hydrochloride at a dose of 5 mg once daily before bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, consider taking this medicine in the morning. Since donepezil reaches steady-state concentrations 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose increase, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. If this medicine is discontinued, its effects gradually diminish; no rebound effect occurs following abrupt discontinuation. ○ Women aged 85 years or older with low body weight: Careful monitoring is required because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg daily.
○ Children: There is no experience with use in children.
This drug contains Donepezil Hydrochloride and is used for the treatment of Alzheimer's dementia. This drug should not be administered to certain patients. For example, women who are pregnant or breastfeeding or patients with allergic reactions to this drug or its components, and patients with genetic lactose intolerance should not take this medication. Patients with heart disease or a history of gastric ulcers should be particularly cautious when using this medication. This medication may slow heart rate or cause arrhythmias, and it may increase gastric acid secretion, worsening peptic ulcers. Patients with a history of asthma or obstructive pulmonary disease should also be cautious as their symptoms may worsen when taking this medication. For patients with extrapyramidal disorders such as Parkinson's disease, caution is needed as this drug may worsen their symptoms. This medication contains a colorant called Tartrazine, which may cause allergic reactions in sensitive patients. Various adverse effects may occur while taking this medication. For example, heart-related problems (syncope, bradycardia, heart block, etc.), gastrointestinal issues (gastric ulcers, bleeding, nausea, vomiting, diarrhea), liver function abnormalities, cerebrovascular issues, motor disturbances, and dyspnea have been reported. Additionally, neurological and systemic symptoms such as hallucinations, insomnia, dizziness, fatigue, myalgia, etc., may occur. This medication should only be used for patients with Alzheimer's dementia and is not approved for other types of dementia or memory impairment. Treatment should be initiated by an experienced physician, with regular assessments of efficacy and adverse reactions. Patients with heart disease or electrolyte disturbances may be at risk of cardiac arrhythmias while taking this medication and may require ECG monitoring. Since this drug is primarily metabolized in the liver, caution is necessary for patients with impaired liver function. It may affect the ability to drive or operate machinery, so caution is advised during the initial stages of treatment or dose escalation. Pregnant or breastfeeding women should refrain from using this medication; if necessary, breastfeeding should be discontinued. This drug may interact with several medications; therefore, those taking other medications should consult their physician or pharmacist. In cases of overdose, serious symptoms such as nausea, vomiting, bradycardia, and respiratory depression may occur, necessitating immediate medical attention, and an antidote called Atropine may be used. This medication should be kept out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture infiltration, ideally at a temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness.
White round film-coated tablets
[For Domestic Use] 30 tablets/bottle, 100 tablets/bottle [For Export] 30 tablets (10 tablets/PTP x3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride 5mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.